Clinical Trials Logo

Clinical Trial Summary

Intrahepatic cholestasis of pregnancy is the most common liver disease in pregnancy. It is is a pregnancy-specific liver disorder with onset mainly in the third trimester of pregnancy. ICP is characterized by pruritus, elevated serum fasting bile salts and transaminases and an increased risk of adverse fetal outcomes. Serum autotaxin levels were found highly sensitive and specific biomarker to to differentiate ICP from other pregnancy-related liver disorders or pruritic dermatoses. The purpose of the study is to determine the diagnostic accuracy of serum autotaxin activity in cholestasis of pregnancy.


Clinical Trial Description

Collected data will enable us to compare serum autotaxin levels in cholestasis of pregnancy and healthy control group. ;


Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT02480478
Study type Observational
Source Sisli Etfal Training & Research Hospital
Contact Hakan Erenel, MD,OBGYN
Phone 00905063092995
Email hakanerenel@yahoo.com
Status Recruiting
Phase N/A
Start date June 2015
Completion date January 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05773677 - Diet in Twin Pregnancy: the Wellness of Mother and Babies. N/A
Completed NCT01499524 - The Metabolic Profile in Intrahepatic Cholestasis of Pregnancy and Diabetes Mellitus
Not yet recruiting NCT01226823 - Ursodeoxycholic Acid And Cholestasis Of Pregnancy Phase 3
Recruiting NCT03834285 - Liver Disease in Pregnancy
Not yet recruiting NCT04890886 - Magnetic Resonance Imaging and Thermal Imaging of Adiposity in Neonates of Women With Metabolic Diseases
Recruiting NCT01906827 - P-wave Duration and Dispersion in Intrahepatic Cholestasis of Pregnancy N/A
Recruiting NCT01898832 - Il-17 Levels in Intrahepatic Cholestasis of Pregnancy N/A
Completed NCT00700232 - ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls N/A
Terminated NCT04718961 - A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA) Phase 2
Completed NCT04922580 - Predictors of Adverse Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy
Recruiting NCT03519399 - Bile Acid Effects in Fetal Arrhythmia Study
Completed NCT05151913 - The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)
Recruiting NCT05691036 - Bile Acids Metabolism and Genetic Mutation Profile in the ICP in the Indian Population
Withdrawn NCT01965054 - The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy N/A
Recruiting NCT05637151 - Different Effects of Delayed Clamping on Neonatal Bilirubin Levels Between Pregnant Women With Intrahepatic Cholestasis of Pregnancy and Normal Pregnant Women N/A
Not yet recruiting NCT06366659 - Unraveling the Pathogenesis of Pruritus in Intrahepatic Cholestasis of Pregnancy
Not yet recruiting NCT06364969 - Investigation of the Pruritogens of Liver-related Diseases